✦ LIBER ✦

Type 2 diabetes and cardiovascular disease in polycystic ovary syndrome: what are the risks and can they be reduced?

✍ Scribed by J. Tomlinson; A. Millward; E. Stenhouse; J. Pinkney

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Type 2 diabetes, cardiovascular disease,

✍ Stephen J. Corbett; Anthony J. McMichael; Andrew M. Prentice 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 364 KB 👁 2 views

Reducing cardiovascular disease risk in

✍ K. L. Rensing; A. Q. Reuwer; B. J. Arsenault; J. H. von der Thüsen; J. B. L. Hoe 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 697 KB

Exercise, fitness, and cardiovascular di

✍ Glen E. Duncan 📂 Article 📅 2006 🏛 Current Science Inc. 🌐 English ⚖ 189 KB

Impaired fibrinolysis and risk for cardi

✍ Susanne Trost; Richard E. Pratley; Burton E. Sobel 📂 Article 📅 2006 🏛 Current Science Inc. 🌐 English ⚖ 437 KB

Reduced GFR and microalbuminuria are ind

✍ H. Yokoyama; M. Oishi; K. Kawai; H. Sone; on behalf of the Japan Diabetes Clinic 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 216 KB

Hepatic inflammation and fibrosis biomar

✍ Morling, JR; Williamson, RM; Robertson, CM; Guha, IN; Fallowfield, JA; Strachan, 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 46 KB